Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OrniFlu in H5N2 LAIV-primed vs Naive Subjects
NCT02153671Phase 2Completed
- Sponsor
- PATH
- Start
- May 2014
- Primary completion
- Sep 2014
- Countries
- 1
01
Overview
A Phase 2 trial of oseltamivir in influenza, sponsored by PATH. Started May 2014; status: completed.
02
Drugs
oseltamivir
03
Conditions
influenza
Beyond the preview
Go deeper on NCT02153671.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02153671.